Kasper Dreyer, Ph.D. Email & Phone Number
Who is Kasper Dreyer, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Kasper Dreyer, Ph.D. is listed as Vice President of Lifecycle Management and Basel Site Head at Ironwood Pharmaceuticals, based in Basel Metropolitan Area, Switzerland, Switzerland. AeroLeads shows a matched LinkedIn profile for Kasper Dreyer, Ph.D..
Kasper Dreyer, Ph.D. previously worked as Head of Global Program Management, Vice President at Pharvaris and Global Program Head at Sandoz. Kasper Dreyer, Ph.D. holds Ph.D., Molecular Biology from Aarhus University.
Email format at Ironwood Pharmaceuticals
This section adds company-level context without repeating Kasper Dreyer, Ph.D.'s masked contact details.
Review company-level records connected to Kasper Dreyer, Ph.D. before choosing the right outreach path.
About Kasper Dreyer, Ph.D.
Experienced drug developer with strong business background. Very passionate about energizing and growing professionals to excel and innovate. Strategic thinker with superior analytical skills to ask the right questions and courage to deliver tough answers.Broad base of 20 years past experiences- Trained in blue chip Pharma and work in fast paced small biotech- Hands on from pre-clinical, through Ph1-Ph3, Registration and Launch prep- Developed Cardiovascular, Metabolism, Immunology and Oncology drugs- Done Strategic Partnerships, Alliances, Outsourcing and contracting- Worked in both Innovator and Generics businesses
Kasper Dreyer, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Kasper Dreyer, Ph.D. work experience
A career timeline built from the work history available for this profile.
Head Of Global Program Management, Vice President
Headed Program Office with 4 PMs supporting, tracking and reporting on drug and non-drug projects across Pharvaris.Lead Pharvaris' 2 main development programs incl. Ph2 to Ph3 transition with HA aligned Ph3 design and strategy.Delivered new Line Extension business case endorsed by Board.
Global Program Head
Global Head of 2 Oncology and 1 Immunology biosimilar development programs.Delivered Ph3 completion, regulatory filing strategy and submission of high quality dossiers to FDA & EMA.Sandoz’ Steering Committee member for two partnership program.
Global Program Head
- Overall responsible for $300m Development Program - Team, Strategy and Execution
- Led clinical study with ~100 FTEs in 39 countries and >10,000 patients enrolled to successful completion
- Developed and drove bold submission strategy recognizing evolving market conditions
- Ensured high quality regulatory filings and led global team through US and RoW registration processes
- Co-led launch preparations with Brand Director
- Early pipeline GPH – driving decisions on acceleration and termination of research assets
Senior Global Program Team Director
- Successfully sustained high performing global program team over a 6 year phase III study
- Oversight of all line function deliverables - Clinical dev plan, IB, integrated product strategy, Value Dossier, etc
- Budget responsible for $50mio annual program budget
- Due Diligence leader
Global Program Team Director
- Led global program team through initiation of major clinical phase III study across 39 countries, incl. JP & CN
- Drove numerous clinical and commercial indication expansion evaluations
- Facilitated improved clinical operations and productivity savings of ~35 mUSD
Senior Portfolio Manager
- Developed new portfolio prioritization framework for Global Development; eliminating resourcing inefficiencies
- Revamped portfolio management in Cardiometabolic Development Unit to support portfolio trade-off decisions
- Only portfolio manager nominated as core member of a Franchise Mgmt Board
Global Portfolio Manager
- Partner and challenger for program teams approaching significant governance milestones
- Achieved >80% of recommendations made to governance boards endorsed, incl. terminations
- Market Research and BD&L evaluations
Portfolio Analyst
- Conducted 100+ ENPVs - proficiency in forecasting, market assessments, price & access, cannibalization, manufacturing facility investments and terms sheets.
- Authored Novo Nordisk’s Development Project Manual
- Achieved ISO certification through SOP and Governance process optimization
Research Scientist
Research Scientist and Project Manager in Drug Discovery.- Assay development in proprietary high throughput screening- Enzyme kinetics- Recombinant protein production, purification and characterisation- Primary cell culture assays
Kasper Dreyer, Ph.D. education
Ph.D., Molecular Biology
Graduate Diploma, Business Administration, Strategic Management And Corporate Development
Diploma Of Advanced Studies In Pharmaceutical Medicine, Ecpm Unibasel, Switzerland
Master Of Science, Chemistry-Biotechnology
Frequently asked questions about Kasper Dreyer, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Kasper Dreyer, Ph.D. work for?
Kasper Dreyer, Ph.D. works for Ironwood Pharmaceuticals.
What is Kasper Dreyer, Ph.D.'s role at Ironwood Pharmaceuticals?
Kasper Dreyer, Ph.D. is listed as Vice President of Lifecycle Management and Basel Site Head at Ironwood Pharmaceuticals.
Where is Kasper Dreyer, Ph.D. based?
Kasper Dreyer, Ph.D. is based in Basel Metropolitan Area, Switzerland, Switzerland while working with Ironwood Pharmaceuticals.
What companies has Kasper Dreyer, Ph.D. worked for?
Kasper Dreyer, Ph.D. has worked for Ironwood Pharmaceuticals, Pharvaris, Sandoz, Novartis, and Novo Nordisk A/S.
How can I contact Kasper Dreyer, Ph.D.?
You can use AeroLeads to view verified contact signals for Kasper Dreyer, Ph.D. at Ironwood Pharmaceuticals, including work email, phone, and LinkedIn data when available.
What schools did Kasper Dreyer, Ph.D. attend?
Kasper Dreyer, Ph.D. holds Ph.D., Molecular Biology from Aarhus University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial